Stock Market & Financial Investment News

News Breaks February 15, 2013 06:07 EDT DVA DaVita downgraded to Neutral from Buy at Goldman Goldman downgraded DaVita due to valuation. Price target is $120. News For DVA From The Last 14 Days Check below for free stories on DVA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 15, 2013 16:55 EDT DVA Berkshire Hathaway gives quarterly update on stakes Subscribe for More Information May 8, 2013 16:48 EDT DVA Rockwell Medical announces long-term supply agreement with DaVita Subscribe for More Information 16:15 EDT DVA Rockwell Medical signs long-term supply agreement with DaVita "Going forward we expect to see increased sales growth, notably from our CitraPure product line, new product offerings and from the increased commitment in our new supply contract with DaVita," the company said. May 7, 2013 16:50 EDT DVA Berkshire Hathaway in agreement to not take stake larger than 25% in DaVita Subscribe for More Information 16:19 EDT DVA DaVita narrows FY13 operating income view to 1.8B-$1.9B from $1.75B-$1.9B Subscribe for More Information 16:17 EDT DVA DaVita reports Q1 adjusted EPS $1.84, consensus $1.79 Reports Q1 revenue $2.83B, consensus $2.78B. Sign up for a free trial to see the rest of the stories you've been missing.